{"database": "lobbying", "table": "lobbying_activities", "rows": [[797405, "8f91d315-a1aa-4994-9d2f-d06a2cc372b1", "Q2", "KIRKLAND & ELLIS LLP", 21745, "TEVA PHARMACEUTICALS USA", 2009, "second_quarter", "PHA", "House and Senate legislation on biologic medicines.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2009-07-17T13:17:32-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["797405"], "units": {}, "query_ms": 70.5309190088883, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}